loadpatents
name:-0.042618036270142
name:-0.030165910720825
name:-0.0048971176147461
Blokhin; Andrei V. Patent Filings

Blokhin; Andrei V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blokhin; Andrei V..The latest application filed is for "targeting ligands for therapeutic compounds".

Company Profile
4.26.32
  • Blokhin; Andrei V. - Fitchburg WI
  • Blokhin; Andrei V - Fitchburg WI
  • Blokhin; Andrei V. - Madison WI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Targeting Ligands For Therapeutic Compounds
App 20210189394 - Rozema; David B ;   et al.
2021-06-24
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
App 20210180066 - Wong; So ;   et al.
2021-06-17
Compositions and methods for inhibiting gene expression of Hif2alpha
Grant 10,927,373 - Wong , et al. February 23, 2
2021-02-23
Targeting Ligands For Therapeutic Compounds
App 20190211333 - Rozema; David B. ;   et al.
2019-07-11
Targeting ligands for therapeutic compounds
Grant 10,246,709 - Rozema , et al.
2019-04-02
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
App 20190062748 - Rozema; David B. ;   et al.
2019-02-28
Biologically Cleavable Tetrapeptide Linking Agents
App 20180258138 - Carlson; Jeffrey C. ;   et al.
2018-09-13
Disubstituted maleic anhydrides with altered kinetics of ring closure
Grant 10,059,681 - Blokhin , et al. August 28, 2
2018-08-28
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
App 20180230470 - Wong; So ;   et al.
2018-08-16
Disulfide-containing alkyne linking agents
Grant 10,047,361 - Almeida , et al. August 14, 2
2018-08-14
Biologically cleavable tetrapeptide linking agents
Grant 10,005,815 - Carlson , et al. June 26, 2
2018-06-26
Compositions and methods for inhibiting gene expression of Hif2alpha
Grant 9,976,141 - Wong , et al. May 22, 2
2018-05-22
Disulfide-Containing Alkyne Linking Agents
App 20180023084 - Almeida; Aaron ;   et al.
2018-01-25
Disulfide-containing alkyne linking agents
Grant 9,803,201 - Almeida , et al. October 31, 2
2017-10-31
Targeting Ligands For Therapeutic Compounds
App 20170253875 - Rozema; David B. ;   et al.
2017-09-07
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
App 20170022497 - Rozema; David B. ;   et al.
2017-01-26
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
App 20160348107 - Wong; So ;   et al.
2016-12-01
Biologically Cleavable Tetrapeptide Linking Agents
App 20160347793 - Carlson; Jeffrey C. ;   et al.
2016-12-01
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
Grant 9,487,556 - Cheng , et al. November 8, 2
2016-11-08
Disubstituted maleic anhydrides with altered kinetics of ring closure
Grant 9,481,661 - Blokhin , et al. November 1, 2
2016-11-01
Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure
App 20160272605 - Blokhin; Andrei V. ;   et al.
2016-09-22
Disulfide-Containing Alkyne Linking Agents
App 20160272971 - Almeida; Aaron ;   et al.
2016-09-22
Peptide-based in vivo siRNA delivery system
Grant 9,107,957 - Rozema , et al. August 18, 2
2015-08-18
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
App 20150045573 - Cheng; Weijun ;   et al.
2015-02-12
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
Grant 8,802,773 - Rozema , et al. August 12, 2
2014-08-12
Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure
App 20140128584 - Blokhin; Andrei V. ;   et al.
2014-05-08
Peptide-Based In Vivo siRNA Delivery System
App 20130281658 - Rozema; David B ;   et al.
2013-10-24
Peptide-based in vivo siRNA delivery system
Grant 8,501,930 - Rozema , et al. August 6, 2
2013-08-06
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
Grant 8,426,554 - Rozema , et al. April 23, 2
2013-04-23
In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages
App 20120172412 - Rozema; David B. ;   et al.
2012-07-05
Peptide-Based In Vivo siRNA Delivery System
App 20120165393 - Rozema; David B. ;   et al.
2012-06-28
Oligoamine Compounds And Derivatives Thereof For Cancer Therapy
App 20090124832 - Frydman; Benjamin ;   et al.
2009-05-14
Oligoamine compounds and derivatives thereof for cancer therapy
Grant 7,491,849 - Clifford, legal representative , et al. February
2009-02-17
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
Grant 7,453,011 - Clifford, legal representative , et al. November
2008-11-18
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
App 20070287754 - Frydman; Benjamin ;   et al.
2007-12-13
Quinones as disease therapies
Grant 7,253,207 - Blokhin , et al. August 7, 2
2007-08-07
Conformationally restricted polyamine analogs as disease therapies
App 20070161692 - Frydman; Benjamin ;   et al.
2007-07-12
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
Grant 7,235,695 - Frydman , et al. June 26, 2
2007-06-26
Conformationally restricted polyamine analogs as disease therapies
Grant 7,186,825 - Frydman , et al. March 6, 2
2007-03-06
Porphyrin-polyamine conjugates for cancer therapy
App 20060276444 - Frydman; Benjamin ;   et al.
2006-12-07
Porphyrin-polyamine conjugates for cancer therapy
Grant 7,026,347 - Frydman , et al. April 11, 2
2006-04-11
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
App 20060030735 - Frydman; Benjamin ;   et al.
2006-02-09
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
Grant 6,982,351 - Frydman , et al. January 3, 2
2006-01-03
Oligoamine compounds and derivatives thereof for cancer therapy
App 20050080144 - Frydman, Benjamin ;   et al.
2005-04-14
Novel quinones as disease therapies
App 20050010060 - Blokhin, Andrei V. ;   et al.
2005-01-13
Conformationally restricted polyamine analogs as disease therapies
App 20040235962 - Frydman, Benjamin ;   et al.
2004-11-25
Quinones as disease therapies
Grant 6,809,176 - Blokhin , et al. October 26, 2
2004-10-26
Conformationally restricted polyamine analogs as disease therapies
Grant 6,794,545 - Frydman , et al. September 21, 2
2004-09-21
Porphyrin-polyamine conjugates for cancer therapy
App 20040152687 - Frydman, Benjamin ;   et al.
2004-08-05
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
App 20030195377 - Frydman, Benjamin ;   et al.
2003-10-16
Oligoamine compounds and derivatives thereof for cancer therapy
App 20030130356 - Frydman, Benjamin ;   et al.
2003-07-10
Quinones As Disease Therapies
App 20030013677 - Blokhin, Andrei V. ;   et al.
2003-01-16
Novel quinones as disease therapies
App 20020183512 - Blokhin, Andrei V. ;   et al.
2002-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed